Abstract Background The SARS-CoV-2 virus has spread continuously worldwide, characterized by various clinical symptoms. The immune system responds to SARS-CoV-2 …
A Khamis, L Salzer, E Schiegnitz, RH Stauber… - International journal of …, 2023 - mdpi.com
OPMDs (oral potentially malignant disorders) are a group of disorders affecting the oral mucosa that are characterized by aberrant cell proliferation and a higher risk of malignant …
LJ Rosario-Rodríguez, YM Cantres-Rosario… - International Journal of …, 2024 - mdpi.com
Viral strains, age, and host factors are associated with variable immune responses against SARS-CoV-2 and disease severity. Puerto Ricans have a genetic mixture of races …
R Filev, M Lyubomirova, J Hristova, B Bogov… - Journal of Personalized …, 2023 - mdpi.com
In a prospective, observational, non-interventional, single-center study, we assessed various plasma and urinary biomarkers of kidney injury (neutrophil gelatinase-associated Lipocain …
LA Kahar, Y Yusrawati, J Jamsari… - Acta Medica …, 2023 - ncbi.nlm.nih.gov
Objective. This study aimed to determine the role of vitamin D-binding protein (VDBP) gene polymorphisms (especially at locus rs7041), vitamin D-binding protein levels, and vitamin D …
A previously unknown coronavirus, named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in the city of Wuhan, China, in December 2019. Its …
Background Cytokine dysregulation in COVID-19 patients aged over 60 has been associated to adverse outcomes. While serum levels have been studied, cellular expression …
X Cao, Y Xie, C Zhou, H Mu - Biomolecules and Biomedicine, 2024 - ncbi.nlm.nih.gov
Many studies have shown that recovered coronavirus disease 2019 (COVID-19) patients frequently exhibit recurrent viral RNA positivity (RP) for the severe acute respiratory …
C Holetschek, M Goekkaya, K Dorgham, P Eder… - medRxiv, 2024 - medrxiv.org
Background: Whilst SARS-CoV-2 infection has become endemic, COVID-19 related hospitalization and mortality are still considerably high. Both anti-viral and immune …